Krömer, S. A.; Milfay, D.; Wigger, A.; Jacob, W.; Kessler, M.; Bunck, M.; Zimbelmann, M.; Birg, I. N.; Landgraf, R.; Turck, C. W.: Validation of a genetic mouse model for anxiety and comorbid depression. Pharmacopsychiatry 36 (5), S. 242 - 242 (2003)

Lutz, B.; Monory, K.; Hermann, H.; Cannich, A.; Kamprath, K.; Wotjak, C. T.; Marsicano, G.: The roles of the endogenous cannabinoid system in learning and memory in mice. Pharmacopsychiatry 36 (5), S. 245 - 245 (2003)

Lutz, R.; Köhnlein, O.; Minov, C.; Vogel, M.; Eichinger, M.; Messer, T.; Schmauss, M.: Management of the atypical antipsychotic Olanzapine (Zyprexa) in a clinical environment with particular regard to therapeutic drug monitoring (TDM) in a German State Hospital. Pharmacopsychiatry 36 (5), S. 245 - 246 (2003)

Majer, M.; Modell, S.; Holsboer, F.; Zihl, J.: Neuropsychological deficits and long-term outcomes in patients with affective disorders. Pharmacopsychiatry 36 (5), S. 246 - 246 (2003)

Mathias, S.: Modulation of GABAergic systems with GABA agonists and antagonists, effects on sleep EEG and hormone secretion. Pharmacopsychiatry 36 (5), S. 246 - 246 (2003)

Mirowska, D.; Wicha, W.; Czlonkowski, A.; Czlonkowska, A.; Holsboer, F.; Weber, F.: Increase of matrix metalloproteinase-9 in peripheral blood of multiple sclerosis patients treated with high doses of methylprednisolone. Pharmacopsychiatry 36 (5), S. 247 - 247 (2003)

Müller, M. B.; Zimmermann, S.; Sillaber, I.; Hagemeyer, T. P.; Deussing, J.; Droste, S.; Reul, J. H. M. H.; Holsboer, F.; Wurst, W.: Limbic Crhr1 mediates anxiety-related behaviour and is required for hormonal adaptation to stress. Pharmacopsychiatry 36 (5), S. 249 - 249 (2003)

Murck, H.; Held, K.; Auer, D. P.; Steiger, A.: Therapeutic sleep deprivation and magnesium: Modulators of the GABA/glutamate equilibrium. Pharmacopsychiatry 36 (5), S. 250 - 250 (2003)

Murck, H.; Song, C.; Horrobin, D.; Uhr, M.: Ethyl-EPA and dexamethasone-resistance in therapy-refractory depression. Pharmacopsychiatry 36 (5), S. 250 - 250 (2003)

Murgatroyd, C.; Wigger, A.; Spengler, D.; Landgraf, R.: Molecular-genetic dissection of anxiety/depression: From HAB phenotype to functional SNP. Pharmacopsychiatry 36 (5), S. 250 - 251 (2003)

Ohl, F.; Binder, E. B.; Rödel, A.; Weissenbacher, P.; Keck, M. E.: ENU-mouse mutagenesis screen: In search of animal models of psychiatric disorders. Pharmacopsychiatry 36 (5), S. 252 - 252 (2003)

Pfennig, A.; Kuenzel, H. E.; Kern, N.; Fuchs, B.; Brunner, J.; Ising, M.; Modell, S.; Müller-Myhsok, B.; Binder, E. B.; Holsboer, F.: HPA axis dysregulation and suicidal behavior in depression - Differentiation of a genetically distinct subgroup? Pharmacopsychiatry 36 (5), S. 252 - 253 (2003)

Räder, H.; Grunze, H.; Ohl, F.; Keck, M. E.; Giegling, I.; Rujescu, D.: Effects of chronic MK-801 treatment on the relative mRNA expression of NMDA receptor subunits and splice variants in a pharmacological model for psychosis. Pharmacopsychiatry 36 (5), S. 254 - 254 (2003)

Rein, T.; Wochnik, G. M.; Schmidt, U.; Rosenhagen, M.; Holsboer, F.: Role of chaperones in signal transduction of the glucocorticoid receptor. Pharmacopsychiatry 36 (5), S. 255 - 255 (2003)

Rödel, A.; Storch, C.; Ohl, F.: Influence of circadian factors on behavioral and cognitive testing in mice. Pharmacopsychiatry 36 (5), S. 256 - 256 (2003)

Rosenhagen, M.; Maccarrone, G.; Birg, I. N.; Jacob, A.; Uhr, M.; Holsboer, F.; Turck, C. W.: Analysis of cerebrospinal fluid of depressed patients. Pharmacopsychiatry 36 (5), S. 256 - 256 (2003)

Rüegg, J.; Holsboer, F.; Rein, T.: A functional genetic screen to identify factors involved in glucocorticoid receptor (GR) transactivation. Pharmacopsychiatry 36 (5), S. 257 - 257 (2003)

Rupprecht, R.; Eisensamer, B.: Modulation of ligand-gated ion channels by antidepressants. Pharmacopsychiatry 36 (5), S. 258 - 258 (2003)

Rupprecht, R.; Lancel, M.; Friess, E.; Ströhle, A.; Holsboer, F.; Romeo, E.: GABAergic effects of neuroactive steroids: Modulation of sleep and anxiety. Pharmacopsychiatry 36 (5), S. 258 - 258 (2003)

Schiffelholz, T.; Lancel, M.; Holsboer, F.: The youth hormone DHEA: A benefit for pathologic sleep alterations? Pharmacopsychiatry 36 (5), S. 261 - 261 (2003)